Dukes, George E
GI Therapeutic Area Unit, Takeda Pharmaceuticals, Cambridge, MA.
3 papers on CoChatORCID 0009-0007-3404-860X
Most cited papers
- Verified
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double‐blind, randomised, placebo‐controlled, crossover, phase 2a study
Hegade, V. S., Kendrick, S. F. W., Dobbins, R. L., Miller, S. R., Thompson, D., Richards, D., Storey, J., Dukes, G. E., Corrigan, M., Oude Elferink, R. P. J., et al. (2017) · The Lancet
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 206
- Verified
Incidence, Risk Factors, and Clinical Consequence of Enteral Feeding Intolerance in the Mechanically Ventilated Critically Ill: An Analysis of a Multicenter, Multiyear Database
Heyland, D. K., Ortiz, A., Stoppe, C., Patel, J. J., Yeh, D. D., Dukes, G., Chen, Y. J., Almansa, C., & Day, A. G. (2021) · Critical Care Medicine
Clinical Nutrition and GastroenterologyNosocomial Infections in ICU
Cited by 201
- Verified
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα
Swan, C., Duroudier, N. P., Campbell, E., Zaitoun, A., Hastings, M., Dukes, G. E., Cox, J., Kelly, F. M., Wilde, J., Lennon, M. G., et al. (2013) · Gut
Gastrointestinal motility and disordersInflammatory Bowel Disease
Cited by 165
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free